PVR-100/VASOGRAM

K990123 · Vasocor, Inc. · JOM · Apr 12, 1999 · Cardiovascular

Device Facts

Record IDK990123
Device NamePVR-100/VASOGRAM
ApplicantVasocor, Inc.
Product CodeJOM · Cardiovascular
Decision DateApr 12, 1999
DecisionSESE
Submission TypeTraditional
Regulation21 CFR 870.2780
Device ClassClass 2

Intended Use

The PVR-100 / Vasogram is a noninvasive medical device used in conjunction with other devices such as: continuous-wave Doppler ultrasound, treadmill testing, and ultrasonic imaging techniques for vascular studies of the limbs and digits. Use of the PVR-100 / Vasogram in this manner allows the physician to noninvasively diagnosis extremity arterial and venous disorders, and receive, record, and produce a visual display of local arterial compliance.

Device Story

PVR-100/Vasogram II is a noninvasive diagnostic system for vascular studies. Device integrates with continuous-wave Doppler, treadmill testing, and ultrasonic imaging to assess limb and digit vasculature. System captures physiological signals to evaluate arterial and venous disorders; specifically, the Vasogram component measures, records, and displays local arterial compliance. Operated by physicians in clinical settings to aid in the diagnosis of extremity vascular conditions. Output provides visual data on arterial compliance, assisting clinicians in identifying arterial/venous pathology and informing treatment decisions.

Clinical Evidence

No clinical data provided; substantial equivalence based on technological characteristics and intended use comparison to the predicate device.

Technological Characteristics

Noninvasive vascular diagnostic system; integrates with Doppler ultrasound, treadmill, and ultrasonic imaging. Features include signal acquisition for arterial/venous assessment and local arterial compliance measurement. System provides visual display of compliance data. Connectivity and software details not specified.

Indications for Use

Indicated for patients requiring noninvasive vascular assessment of limbs and digits to diagnose arterial and venous disorders. Used by physicians in conjunction with Doppler ultrasound, treadmill testing, or ultrasonic imaging.

Regulatory Classification

Identification

A hydraulic, pneumatic, or photoelectric plethysmograph is a device used to estimate blood flow in a region of the body using hydraulic, pneumatic, or photoelectric measurement techniques.

Predicate Devices

Related Devices

Submission Summary (Full Text)

{0}------------------------------------------------ Image /page/0/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo is circular and contains the words "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" around the perimeter. In the center of the logo is an abstract symbol that resembles an eagle or bird in flight, composed of three curved lines. Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850 APR 1 2 1998 Jeff Raines Ph.D. Vasocor, Inc. Corporate Park of Miami 7705 N.W. 48th Street, Suite 120 Miami, FL 33166 K990123 Re: PVR-100/Vasogram II Requlatory Class: Product Code: JOM Dated: January 13, 1999 Received: January 13, 1999 Dear Dr. Raines: We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval) , it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Requlations, Title 21, Parts 800 to 895. A substantially equivalent determination assumes compliance with the Current Good Manufacturing Practice requirements, as set forth in the Quality System Regulation (QS) for Medical Devices: General regulation (21 CFR Part 820) and that, through periodic QS inspections, the Food and Drug Administration (FDA) will verify such assumptions. Failure to comply with the GMP regulation may result in regulatory action. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please note: this response to your premarket notification submission does not affect any {1}------------------------------------------------ Page 2 - Mr. Edward F. Waddell obligation you might have under sections 531 through 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal laws or regulations. This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4648. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, 2 Misbranding by reference to premarket notification² (21CFR 807.97). Other qeneral information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its internet address "http://www.fda.gov/cdrh/dsma/dsmamain.html". Sincerely yours, sincerely, yours, Thomas J. Callahan Thomas J. Callahan, Ph.D. Director Division of Cardiovascular, Respiratory, and Neurological Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosure {2}------------------------------------------------ ## 8.0 Intended Use In 510(k) K973659 for the Vasocor PVR-100 (Pulse Volume Recorder), the indications for use statement is as follows: The PVR-100 is a noninvasive medical device used in conjunction with other devices such as: continuous-wave Doppler ultrasound, treadmill testing, and ultrasonic imaging techniques for vascular studies of the limbs and digits. Use of the PVR-100 in this manner allows the physician to noninvasively diagnosis extremity arterial and venous disorders. The addition of the Vasogram to the PVR-100 expands the indications for use statement for the PVR-100 / Vasogram is given in its entirety as follows: The PVR-100 / Vasogram is a noninvasive medical device used in conjunction with other devices such as: continuous-wave Doppler ultrasound, treadmill testing, and ultrasonic imaging techniques for vascular studies of the limbs and digits. Use of the PVR-100 / Vasogram in this manner allows the physician to noninvasively diagnosis extremity arterial and venous disorders, and receive, record, and produce a visual display of local arterial compliance. Wolf Scupstein MD ision of Cardiovascular, Respira and Neurological Devices 510(k) Number Vasocor, Inc. PVR-100 / Vasogram January 13, 1999
Innolitics
510(k) Summary
Decision Summary
Classification Order
Enter a record ID and click Load to view the document.
100%